Purpose
|
Antianginal agent with antiarrhythmic properties that acts as a partial fatty acid oxidation inhibitor. Activates pyruvate dehydrogenase in ischemic myocytes to promote glucose oxidation, switching substrate utilization from fatty acids to glucose.
|
Characteristics
|
Tradename: RANEXA Source of Compound: synthetic, RS-43285-003, CVT-303 Target: Sodium Channel,Calcium Channel Receptor: Sodium channel,Calcium Channel Status: USAN, INN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
99?%
|
Formula
|
C24H35Cl2N3O4
|
Solubility
|
Soluble in DMSO
|